Leukemia, or blood cancer, is a group of complex and diverse malignancies characterized by the uncontrolled growth of white blood cells in the bone marrow and blood system. The main types of leukemia are divided into acute and chronic, and are also classified according to the precursor cells (lymphoblasts or myeloblasts). Leukemia can occur in both children and adults, and its clinical manifestations vary depending on the type and stage of the disease. The main symptoms may include fever, fatigue, frequent bleeding, and a tendency to infections. The disease requires rapid diagnosis and immediate treatment to increase the chances of a successful outcome and improve the quality of life of patients.
History of the disease and interesting historical facts
Leukemia was first described in the scientific literature in the mid-19th century, when Viennese pathologist Rudolf Virchow reported his observations of a white blood cell found in the bone marrow of patients with anemia. In 1845, Italian physician Luigi Galli expressed interest in the condition, leading to the name leukemia, derived from the Greek leukos, meaning white. Over the following decades, it became possible to distinguish different subtypes of leukemia, and it was not until the 20th century that methods for diagnosing and treating them were developed. With the development of molecular genetics, researchers discovered specific chromosomal mutations associated with certain subtypes, which provided impetus for the study of the pathogenesis of the disease and targeted therapies.
Epidemiology
According to the latest data, the incidence of leukemia varies depending on the geographic region, age and ethnicity. According to statistics, more than 10 thousand new cases of leukemia are diagnosed in Russia every year, which is about 5% of all malignant neoplasms. In the United States, 21,000 cases are registered, with the incidence rate among men being slightly higher than among women. Leukemia is most often detected in children aged 2 to 5 years, as well as in adults over 60. It is worth noting that chronic forms of leukemia are more common in older people.
Genetic predisposition to this disease
Leukemia, like many other cancers, has a genetic predisposition. The main mutations associated with the development of leukemia include:
- Fusion of the VAF1 and BCR genes leading to chronic myelogenous leukemia;
- Mutations in the TP53 gene, which is responsible for cell cycle control;
- Alterations in FLT3 and NPM1 genes associated with acute myeloid leukemia.
Clinical studies show that carriers of certain chromosomal abnormalities have a much higher risk of developing the disease. It is important to note that the hereditary form of leukemia is rare, but certain groups of people with genetic mutations may be predisposed to the disease.
Risk factors for the development of this disease
Although the exact causes of leukemia are not fully understood, there are several risk factors that can contribute to its occurrence:
- Long-term exposure to ionizing radiation;
- Contact with chemicals such as benzene and formaldehyde;
- Some viral infections, such as Epstein-Barr virus;
- Pre-existing blood disorders such as Down syndrome or aplastic anemia.
Additionally, age, gender, and family history of the disease are also considered significant factors that increase the risk of leukemia.
Diagnosis of this disease
Diagnosis of leukemia requires a multi-stage approach and includes clinical and laboratory studies. The main symptoms of the disease may manifest as:
- Unexplained fever;
- Frequent infections;
- Bleeding and bruising;
- Anemia and weakness.
To confirm the diagnosis, the following laboratory tests are performed:
- General blood test with determination of the level of leukocytes and platelets;
- Bone marrow biopsy to determine the type of leukemia;
- Cytogenetic analysis to detect chromosomal abnormalities.
In addition, radiological examinations such as X-ray, CT and MRI can help in assessing the extent of the disease. Differential diagnosis should include other hypoplastic and myeloproliferative disorders.
Treatment
Treatment for leukemia depends heavily on the type and stage of the disease. The main approaches are:
- Chemotherapy is the standard treatment for most forms of leukemia;
- Blood transfusions to compensate for anemia and platelet deficiency;
- Radiation therapy to reduce the number of leukemia cells;
- Stem cell transplantation for high risk of relapse.
Pharmacological treatment includes targeted agents such as tyrosine kinase inhibitors and monoclonal antibodies. In some cases, surgery may be recommended if complications arise, such as splenectomy (removal of the spleen) for hypersplenism. Other approaches, including immunotherapy, are in clinical trials.
List of medications used to treat this disease
There are many medications used in the treatment of leukemia. The main ones include:
- Immatinib (Gleevec), a tyrosine kinase inhibitor;
- Derusetinib, a selective inhibitor;
- Cytarabine, used in chemotherapy of acute leukemia;
- Doxorubicin for chemotherapy;
- Rituximab, used in the treatment of chronic lymphocytic leukemia.
Each of these drugs has its own indications, contraindications and side effects. Therapy should be prescribed only by a qualified medical specialist.
Disease monitoring
Monitoring of patients with leukemia includes regular follow-up examinations aimed at early detection of relapses and complications. The main stages of monitoring include:
- Periodic blood tests to assess white blood cell levels;
- Bone marrow biopsy if needed to assess chemotherapy response;
- Screening for possible complications such as infectious diseases or thrombocytopenia.
A patient's prognosis depends on many factors, including the type of leukemia, the stage at diagnosis, and the response to treatment. Complications such as infections and the need for organ transplants can significantly complicate treatment and reduce the chances of recovery.
Age-related features of the disease
Leukemia progresses differently in children and adults. Children often have acute lymphoblastic leukemia, which in most cases responds well to treatment. Adults often have chronic myelogenous leukemia and acute myelogenous leukemia, which are aggressive. Elderly people are at risk, for whom leukemia can progress more severely and with greater complications. In elderly patients, diseases often correspond with other comorbid conditions, which complicates treatment.
Questions and Answers
- What are the main symptoms of leukemia? The main symptoms include fever, non-healing wounds, rapid fatigue, frequent infections and bleeding.
- What are the main treatments for leukemia? The main treatment methods are chemotherapy, stem cell transplantation, radiation therapy and targeted therapy.
- Is there a chance for a full recovery? Yes, depending on the type and stage of the disease, as well as the response to treatment, there is a possibility of complete recovery.
- What is the role of genetics in the development of leukemia? Genetics can influence susceptibility to the disease, and some gene mutations are associated with an increased risk of leukemia.
- What is the likelihood of relapse after treatment? The likelihood of relapse depends on the type of leukemia and the individual's response to treatment. Regular monitoring can reduce the risks.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends the following:
- Get regular medical checkups, especially if you have a family history of leukemia;
- Pay attention to any changes in how you feel, especially symptoms such as fever and fatigue;
- Maintain a healthy lifestyle, including proper nutrition and physical activity, to strengthen your immune system;
- Do not neglect a medical examination if you work in hazardous conditions or with chemicals.
The doctor emphasizes the importance of early medical attention and providing psychosocial support to both the patient and his or her loved ones.
